Effect of stearyl alcohol on imiquimod‐induced psoriasis‐like skin inflammation in mice

Abstract Psoriasis is a chronic inflammatory skin disease. Topical medicines are the preferred treatment for mild to moderate psoriasis, but the effect of excipients used in semi‐solid preparations on psoriasis‐like skin inflammation is not fully understood. In the present study, we investigated the effect of stearyl alcohol, a commonly used excipient, on imiquimod (IMQ)‐induced psoriasis‐like skin inflammation in mice. Psoriasis‐like skin inflammation was induced by topical IMQ treatment on the back of mice. Skin lesion severity was evaluated by using psoriasis area and severity index (PASI) scores. The skin sections were stained by haematoxylin–eosin and immunohistochemistry. Stearyl alcohol (20% in vaseline) treatment significantly reduced the IMQ‐induced increase of PASI scores and epidermal thickness in mice. IMQ treatment increased the number of Ki67‐ and proliferating cell nuclear antigen (PCNA)‐positive cells in the skin, and the increases were inhibited by stearyl alcohol (20% in vaseline) treatment. Stearyl alcohol treatment (1%, 5%, 10% in vaseline) dose‐dependently ameliorated IMQ‐induced increase of PASI scores and epidermal thickness in mice. Hexadecanol (20% in vaseline), stearic acid (20% in vaseline) and vaseline treatment had no significant effect on IMQ‐induced psoriasis‐like skin inflammation in mice. In conclusion, stearyl alcohol has the effect of improving IMQ‐induced psoriasis‐like skin inflammation in mice.